Early Access - bridging innovation and commercialization of therapies
This year Inceptua can celebrate its 25th anniversary....
Read More
Vice President, Global Regulatory Affairs Joins Inceptua Early Access
Vice President, Global Regulatory Affairs Joins Inceptua Early...
Read More
World-Leading Regulatory Affairs Expert Joins Inceptua Group
World-Leading Regulatory Affairs Expert Joins Inceptua Group Luxembourg,...
Read More
Inceptua Strengthening Presence in China
Inceptua Strengthening Presence in China Inceptua’s presence in...
Read More
Inceptua receives approval of marketing authorization transfer of Apealea® (paclitaxel micellar) for the treatment of ovarian cancer
European Commission and MHRA approves transfer of marketing...
Read More
Brexit and Clinical Trial Supply - Understand and Manage the Impact
Inceptua presenting at Clinical Trial East Coast 2021...
Read More
Inceptua strengthens early access division with key business development hire
Lorem ipsum dolor sit amet, consectetur adipiscing elit....
Read More
Assess and Manage Risks in the Clinical Trial Supply Chain
Inceptua presenting at The GCSG 2021 European Virtual...
Read More
Is there a role for Ethics Committees in Early Access?
Lorem ipsum dolor sit amet, consectetur adipiscing elit....
Read More
Elevar Therapeutics Inc. Announces Licensing Agreement with Inceptua Group
Lorem ipsum dolor sit amet, consectetur adipiscing elit....
Read More
Inceptua Q&A: What is Early Access?
Lorem ipsum dolor sit amet, consectetur adipiscing elit....
Read More
Inceptua Partners with Global Blood Therapeutics for an Early Access Program for Voxelotor for Patients with Sickle Cell Disease
Lorem ipsum dolor sit amet, consectetur adipiscing elit....
Read More
Webinar: Strategic Comparator Sourcing in China
Lorem ipsum dolor sit amet, consectetur adipiscing elit....
Read More
Safely and Reliably Supplying your Comparator Needs during COVID19
Lorem ipsum dolor sit amet, consectetur adipiscing elit....
Read More
Maintaining access to your medicines during COVID19
Lorem ipsum dolor sit amet, consectetur adipiscing elit....
Read More